Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 2

Results: 21

Correction to: OSCC cell‑secreted exosomal CMTM6 induced M2‑like macrophages polarization via ERK1/2 signaling pathway.
Published in:
2022
By:
- Pang, Xin;
- Wang, Sha‑sha;
- Zhang, Mei;
- Jiang, Jian;
- Fan, Hua‑yang;
- Wu, Jia‑shun;
- Wang, Hao‑fan;
- Liang, Xin‑hua;
- Tang, Ya‑ling
Publication type:
Correction Notice
Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 491, doi. 10.1007/s00262-021-03012-4
By:
- Wang, Chao;
- Shi, Min;
- Zhang, Lei;
- Ji, Jun;
- Xie, Ruyan;
- Wu, Chao;
- Guo, Xianchao;
- Yang, Ying;
- Zhou, Wei;
- Peng, Chenhong;
- Zhang, Henghui;
- Yuan, Fei;
- Zhang, Jun
Publication type:
Article
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 473, doi. 10.1007/s00262-021-03010-6
By:
- Narla, Rama Krishna;
- Modi, Hardik;
- Bauer, Daniel;
- Abbasian, Mahan;
- Leisten, Jim;
- Piccotti, Joseph R.;
- Kopytek, Stephan;
- Eckelman, Brendan P.;
- Deveraux, Quinn;
- Timmer, John;
- Zhu, Dan;
- Wong, Lilly;
- Escoubet, Laure;
- Raymon, Heather K.;
- Hariharan, Kandasamy
Publication type:
Article
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 461, doi. 10.1007/s00262-021-03000-8
By:
- Kobayashi, Takashi;
- Ito, Katsuhiro;
- Kojima, Takahiro;
- Maruyama, Satoru;
- Mukai, Shoichiro;
- Tsutsumi, Masakazu;
- Miki, Jun;
- Okuno, Tomoya;
- Yoshio, Yuko;
- Matsumoto, Hiroaki;
- Shimazui, Toru;
- Segawa, Takehiko;
- Karashima, Takashi;
- Masui, Kimihiko;
- Fukuta, Fumimasa;
- Tashiro, Kojiro;
- Imai, Kazuto;
- Suekane, Shigetaka;
- Nagasawa, Seiji;
- Higashi, Shin
Publication type:
Article
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 445, doi. 10.1007/s00262-021-02998-1
By:
- Kursunel, M. Alper;
- Taskiran, Ekim Z.;
- Tavukcuoglu, Ece;
- Yanik, Hamdullah;
- Demirag, Funda;
- Karaosmanoglu, Beren;
- Ozbay, Feyza Gul;
- Uner, Aysegul;
- Esendagli, Dorina;
- Kizilgoz, Derya;
- Yilmaz, Ulku;
- Esendagli, Gunes
Publication type:
Article
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 387, doi. 10.1007/s00262-021-02997-2
By:
- Jo, Hitomi;
- Yoshida, Tatsuya;
- Horinouchi, Hidehito;
- Yagishita, Shigehiro;
- Matsumoto, Yuji;
- Shinno, Yuki;
- Okuma, Yusuke;
- Goto, Yasushi;
- Yamamoto, Noboru;
- Takahashi, Kazuhisa;
- Motoi, Noriko;
- Ohe, Yuichiro
Publication type:
Article
SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 399, doi. 10.1007/s00262-021-02995-4
By:
- Yuan, Lu;
- Wu, Xixi;
- Zhang, Longshan;
- Yang, Mi;
- Wang, Xiaoqing;
- Huang, Wenqi;
- Pan, Hua;
- Wu, Yuting;
- Huang, Jihong;
- Liang, Wenyu;
- Li, Jiaxin;
- Zhu, Xiaodi;
- Wang, Shuang;
- Guan, Jian;
- Liu, Laiyu
Publication type:
Article
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 365, doi. 10.1007/s00262-021-02994-5
By:
- Takeuchi, Eiji;
- Okano, Yoshio;
- Machida, Hisanori;
- Atagi, Katsuhiro;
- Kondou, Yoshihiro;
- Kadota, Naoki;
- Hatakeyama, Nobuo;
- Naruse, Keishi;
- Shinohara, Tsutomu
Publication type:
Article
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 433, doi. 10.1007/s00262-021-02993-6
By:
- Holmberg-Thydén, Staffan;
- Dufva, Inge Høgh;
- Gang, Anne Ortved;
- Breinholt, Marie Fredslund;
- Schejbel, Lone;
- Andersen, Mette Klarskov;
- Kadivar, Mohammad;
- Svane, Inge Marie;
- Grønbæk, Kirsten;
- Hadrup, Sine Reker;
- El Fassi, Daniel
Publication type:
Article
T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 339, doi. 10.1007/s00262-021-02992-7
By:
- Harada, Mamoru;
- Iida, Yuichi;
- Kotani, Hitoshi;
- Minami, Takafumi;
- Komohara, Yoshihiro;
- Eto, Masatoshi;
- Yoshikawa, Kazuhiro;
- Uemura, Hirotsugu
Publication type:
Article
Gastric cancer-derived exosomal miR-135b-5p impairs the function of Vγ9Vδ2 T cells by targeting specificity protein 1.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 311, doi. 10.1007/s00262-021-02991-8
By:
- Li, Juntao;
- Sun, Linqing;
- Chen, Yanjun;
- Zhu, Jinghan;
- Shen, Jin;
- Wang, Jiayu;
- Gu, Yanzheng;
- Zhang, Guangbo;
- Wang, Mingyuan;
- Shi, Tongguo;
- Chen, Weichang
Publication type:
Article
Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 373, doi. 10.1007/s00262-021-02990-9
By:
- Lazarus, Gilbert;
- Budiman, Refael Alfa;
- Rinaldi, Ikhwan
Publication type:
Article
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 353, doi. 10.1007/s00262-021-02989-2
By:
- Ni, Haiqing;
- Cao, Lei;
- Wu, Zhihai;
- Wang, Li;
- Zhou, Shuaixiang;
- Guo, Xiaoli;
- Gao, Yarong;
- Jing, Hua;
- Wu, Min;
- Liu, Yang;
- Ding, Jiazheng;
- Zhang, Pan;
- Zhou, Ying;
- Chen, Bingliang;
- Xiong, Yao;
- Sun, Jiya;
- Prinz, Bianka;
- Baruah, Hemanta;
- Geoghegan, James;
- Yu, Michael
Publication type:
Article
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 417, doi. 10.1007/s00262-021-02973-w
By:
- Italiano, Antoine;
- Cassier, Philippe A.;
- Lin, Chia-Chi;
- Alanko, Tuomo;
- Peltola, Katriina J.;
- Gazzah, Anas;
- Shiah, Her-Shyong;
- Calvo, Emiliano;
- Cervantes, Andrés;
- Roda, Desamparados;
- Tosi, Diego;
- Gao, Bo;
- Millward, Michael;
- Warburton, Lydia;
- Tanner, Minna;
- Englert, Stefan;
- Lambert, Stacie;
- Parikh, Apurvasena;
- Afar, Daniel E.;
- Vosganian, Gregory
Publication type:
Article
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 301, doi. 10.1007/s00262-021-02987-4
By:
- Ye, Ruiting;
- Zeng, Han;
- Liu, Zhaopei;
- Jin, Kaifeng;
- Liu, Chunnan;
- Yan, Sen;
- Yu, Yanze;
- You, Runze;
- Zhang, Hongyi;
- Chang, Yuan;
- Wang, Yiwei;
- Liu, Li;
- Zhu, Yu;
- Xu, Jiejie;
- Xu, Le;
- Wang, Zewei
Publication type:
Article
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 289, doi. 10.1007/s00262-021-02984-7
By:
- Marijt, Koen A.;
- Griffioen, Lisa;
- Blijleven, Laura;
- van der Burg, Sjoerd. H.;
- van Hall, Thorbald
Publication type:
Article
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 251, doi. 10.1007/s00262-021-02981-w
By:
- Budczies, Jan;
- Kirchner, Martina;
- Kluck, Klaus;
- Kazdal, Daniel;
- Glade, Julia;
- Allgäuer, Michael;
- Kriegsmann, Mark;
- Heußel, Claus-Peter;
- Herth, Felix J.;
- Winter, Hauke;
- Meister, Michael;
- Muley, Thomas;
- Goldmann, Torsten;
- Fröhling, Stefan;
- Wermke, Martin;
- Waller, Cornelius F.;
- Tufman, Amanda;
- Reck, Martin;
- Peters, Solange;
- Schirmacher, Peter
Publication type:
Article
Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 277, doi. 10.1007/s00262-021-02978-5
By:
- Liu, Guanfang;
- Zhang, Qi;
- Yang, Jingying;
- Li, Xiaomin;
- Xian, Luhua;
- Li, Wenmin;
- Lin, Ting;
- Cheng, Juan;
- Lin, Qiwen;
- Xu, Xiuzhang;
- Li, Qin;
- Lin, Yu;
- Zhou, Maohua;
- Shen, Erxia
Publication type:
Article
T cells, particularly activated CD4<sup>+</sup> cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 237, doi. 10.1007/s00262-021-02976-7
By:
- Wang, Zhaoming;
- Chimenti, Michael S.;
- Strouse, Christopher;
- Weiner, George J.
Publication type:
Article
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 327, doi. 10.1007/s00262-021-02985-6
By:
- Fountzilas, Elena;
- Lampaki, Sofia;
- Koliou, Georgia-Angeliki;
- Koumarianou, Anna;
- Levva, Sofia;
- Vagionas, Anastasios;
- Christopoulou, Athina;
- Laloysis, Athanasios;
- Psyrri, Amanda;
- Binas, Ioannis;
- Mountzios, Giannis;
- Kentepozidis, Nikolaos;
- Kotsakis, Athanassios;
- Saloustros, Emmanouil;
- Boutis, Anastasios;
- Nikolaidi, Adamantia;
- Fountzilas, George;
- Georgoulias, Vassilis;
- Chrysanthidis, Miltiadis;
- Kotteas, Elias
Publication type:
Article
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 267, doi. 10.1007/s00262-021-02964-x
By:
- Wang, Yang;
- Nie, Jun;
- Dai, Ling;
- Hu, Weiheng;
- Zhang, Jie;
- Chen, Xiaoling;
- Ma, Xiangjuan;
- Tian, Guangming;
- Han, Jindi;
- Han, Sen;
- Wu, Di;
- Long, Jieran;
- Zhang, Ziran;
- Fang, Jian
Publication type:
Article